RVPH
USDReviva Pharmaceuticals Holdings Inc. Common Stock
$0.553-0.017 (-2.982%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.570
High
$0.595
Low
$0.530
Volume
5.53M
Company Fundamentals
Market Cap
53.3M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
9.52M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.25Current $0.553High $4.28
Related News
Analyst Upgrades
D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $2 Price Target
D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals with a Buy and maintains $2 price target.
View more
Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Reviva Pharmaceuticals, Lowers Price Target to $4
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Reviva Pharmaceuticals with a Buy and lowers the price target from $11 to $4.
View more
GlobeNewswire
Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners
CUPERTINO, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.